DNA R&D to Revenue
Ginkgo Bioworks Holdings Inc Class · R&D to Revenue
DNA R&D to Revenue
Latest reported143.27%period ending
DNA FY R&D/Revenue (177.73% → 143.27%)
Latest values, visible window
High-resolution chart · PNG
DNA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 143.2653% | |
| 186.7756% | |
| 230.9045% | |
| 220.3537% | |
| 366.3246% | |
| 208.418% | |
| 177.7259% |